PRVA
Get informed when a big investor buys or sells
+ FollowUndervalued by 122.6% based on the discounted cash flow analysis.
| Market cap | $2.83 Billion |
|---|---|
| Enterprise Value | $-400,638,022,204.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.19 |
| Beta | 0.84 |
| Outstanding Shares | 126,121,426 |
| P/E Ratio | 99.82 |
|---|---|
| PEG | 42.17 |
| Price to Sales | 1.21 |
| Price to Book Ratio | 0.0 |
| Enterprise Value to Revenue | -169.9 |
| Enterprise Value to EBIT | -7629.17 |
| Enterprise Value to Net Income | -33 |
| Total Debt to Enterprise | -0.02 |
| Debt to Equity | 0.01 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 35.27%▼ 62.09% |
|---|---|
| Total Invested | $1.13B▼ 54.69% |
| Investors Holding | 119▼ 177.00% |
No data
Privia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for del...